BioCentury
ARTICLE | Company News

Vectura, Boehringer Ingelheim deal

January 25, 2016 8:00 AM UTC

Vectura disclosed that its partner for a 2011 deal to develop and commercialize VR315 is Boehringer’s Roxane Laboratories Inc. subsidiary. Vectura has received $12 million in milestone payments under...